FSENX
Price
$81.85
Change
-$2.11 (-2.51%)
Updated
Jun 5 closing price
Net Assets
3.67B
RYEAX
Price
$298.62
Change
-$11.13 (-3.59%)
Updated
Jun 5 closing price
Net Assets
52.27M
Interact to see
Advertisement

FSENX vs RYEAX

Header iconFSENX vs RYEAX Comparison
Open Charts FSENX vs RYEAXBanner chart's image
FSENX vs RYEAX Comparison Chart in %
View a ticker or compare two or three
VS
FSENX vs. RYEAX commentary
Jun 07, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FSENX is a Hold and RYEAX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
FSENX has more cash in the bank: 3.67B vs. RYEAX (52.3M). RYEAX pays higher dividends than FSENX: RYEAX (2.19) vs FSENX (1.63). FSENX was incepted earlier than RYEAX: FSENX (45 years) vs RYEAX (28 years). RYEAX (1.67) is less costly to investors than FSENX (0.65). RYEAX is a more actively managed with annual turnover of: 534.00 vs. FSENX (14.00). FSENX has a lower initial minimum investment than RYEAX: FSENX (0) vs RYEAX (2500). FSENX annual gain was more profitable for investors over the last year : 52.59 vs. RYEAX (49.29). FSENX return over 5 years is better than : 166.14 vs. RYEAX (112.10).
FSENXRYEAXFSENX / RYEAX
Total Expense Ratio0.651.6240%
Annual Report Gross Expense Ratio0.651.6739%
Fund Existence45 years28 years-
Gain YTD33.31431.551106%
Front LoadN/AN/A-
Min. Initial Investment02500-
Min. Initial Investment IRAN/AN/A-
Net Assets3.67B52.3M7,011%
Annual Yield % from dividends1.632.1975%
Returns for 1 year52.5949.29107%
Returns for 3 years67.5454.22125%
Returns for 5 years166.14112.10148%
Returns for 10 years123.1368.29180%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CXW23.210.15
+0.65%
CoreCivic
GV0.24N/A
-0.04%
Visionary Holdings Inc.
UFI4.11-0.06
-1.44%
UNIFI
SUN66.25-1.02
-1.52%
Sunoco LP
EDIT2.71-0.28
-9.36%
Editas Medicine